A marked response to icotinib in a patient with large cell neuroendocrine carcinoma harboring an EGFR mutation: A case report.

Wang, Yuehong; Shen, Yi Hong; Ma, Shanni; Zhou, Jianying

Wang, Yuehong; Shen, Yi Hong; Ma, Shanni; Zhou, Jianying.

Afiliação

Wang Y; Department of Respiratory Disease, The First Affiliated Hospital of the College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Shen YH; Department of Respiratory Disease, The First Affiliated Hospital of the College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Ma S; Department of Respiratory Disease, The First Affiliated Hospital of the College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Zhou J; Department of Respiratory Disease, The First Affiliated Hospital of the College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.

Oncol Lett ; 10(3): 1575-1578, 2015 Sep.

Article em En | MEDLINE | ID: mdl-26622712

Palavras-chave

epidermal growth factor receptor-tyrosine kinase inhibitor; icotinib therapy; large cell neuroendocrine carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google